Literature DB >> 26199163

Pediatric Priapism Secondary to Psychotherapeutic Medications.

William R Armstrong1, Gwen M Grimsby2, Micah A Jacobs3.   

Abstract

With the increased application of many different drug classes for the treatment of psychiatric conditions in children, the incidence of priapism has also increased. Priapism of pharmacotherapeutic etiology in the pediatric population is a complex and poorly understood entity that continues to present new management challenges for clinicians. We present 2 cases of pediatric priapism thought to be secondary to the use of pharmacotherapeutic agents. In the first case, sertraline, an antidepressant, and in the second case, atomoxetine, a nonstimulant medication, are implicated as the most likely causative agents. Both medications have a growing association with priapism in the literature.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26199163     DOI: 10.1016/j.urology.2015.05.006

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients.

Authors:  Salam Alkindi; Said S Almufargi; Anil Pathare
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

Review 2.  Review of Ischemic and Non-ischemic Priapism.

Authors:  Mark G Biebel; Martin S Gross; Ricardo Munarriz
Journal:  Curr Urol Rep       Date:  2022-05-10       Impact factor: 3.092

3.  Methylphenidate-induced priapism in a prepubertal boy.

Authors:  Nidhi Chauhan; Sandeep Grover; Vandana Patidar
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.